After a stunning plunge following its 2021 IPO, medical and lifestyle apparel company FIGS, Inc. (NYSE: FIGS) has roared back to life, trading at a price it hasn’t touched in nearly four years. The stock, currently trading above $17, has surged almost 260% over the past year, including a 58% spike in the last month alone.
The rally has been fueled by strong earnings reports and a wave of bullish analyst commentary. Yet despite the positive momentum and sentiment, the consensus 12-month price target for the stock is just $12.25—almost 30% below its current price. This raises the question: how much of this recovery is supported by fundamentals, and how much is momentum? A closer look at FIGS’ history and recent earnings offers some clues. Early investors in FIGS saw a quick windfall after the company’s IPO, which debuted in May 2021 at $22 per share and, within a month, surged to $50 per share.
